← Leaderboards
Sarah E Clark
University Of Colorado Denver
$2,532,303
Attributed
$2,532,303
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $686K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,532,303 · 4
By mechanism
R01$1,475,007 · 1
R21$583,125 · 1
K22$310,445 · 1
F32$163,726 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Randall K Holmes$18,378,539
- Ellen L Burnham$17,290,816
- Brent E Palmer$8,372,659
- Thomas B. Campbell$27,628,296
- Achim Klug$7,193,248
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionMyeloid CellsInterleukin-10ImmunePredispositionProductionMediatingSignal TransductionRecruitStreptococcus PneumoniaeCellsInflammationPathogenResponseLungBacteriaCo-InfectionCell TypeCytokineIn VitroProteinsPathway InteractionsAnti-Inflammatory AgentsImmunotherapy
Grant awards (12)
Airway Prevotella enhance innate immune-mediated protection against lung infection$491,669
R01 · FY2025 · AI · contact PI
Airway Prevotella enhance innate immune-mediated protection against lung infection$491,669
R01 · FY2024 · AI · contact PI
Host factors influencing early clearance of Streptococcus pneumoniae from the middle ear following invasion from the nasopharynx$194,375
R21 · FY2024 · DC · contact PI
Airway Prevotella enhance innate immune-mediated protection against lung infection$491,669
R01 · FY2023 · AI · contact PI
Host factors influencing early clearance of Streptococcus pneumoniae from the middle ear following invasion from the nasopharynx$194,375
R21 · FY2023 · DC · contact PI
Host factors influencing early clearance of Streptococcus pneumoniae from the middle ear following invasion from the nasopharynx$194,375
R21 · FY2022 · DC · contact PI
Bacterial-driven immune suppression in the lung$40,445
K22 · FY2021 · AI · contact PI
Bacterial-driven immune suppression in the lung$108,000
K22 · FY2020 · AI · contact PI
Bacterial-driven immune suppression in the lung$162,000
K22 · FY2019 · AI · contact PI
Natural killer cell-derived IL-10 and immunity to Listeria$58,002
F32 · FY2016 · AI · contact PI
Natural killer cell-derived IL-10 and immunity to Listeria$54,194
F32 · FY2015 · AI · contact PI
Natural killer cell-derived IL-10 and immunity to Listeria$51,530
F32 · FY2014 · AI · contact PI